Skip to main content

Advertisement

Log in

Questionable role of adjuvant chemotherapy in rectal cancer patients who had reached pathological complete response after neoadjuvant concurrent chemoradiotherapy: no matter in the East or in the West

  • Letter to the Editor
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  • Capirci C, Valentini V, Cionini L et al (2008) Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 72:99–107

    Article  PubMed  Google Scholar 

  • Chien CR, Shih YC (2013) Use of personalized decision analysis in decision making for palliative vs. surgical management of the oldest–old patients with localized skin cancer in a culturally sensitive environment: a case study of a 96-year-old male Taiwanese patient. J Pain Symptom Manage 45:792–797

    Article  PubMed  Google Scholar 

  • Geva R, Itzkovich E, Shamai S, Shacham-Shmueli E, Soyfer V, Klausner JM, Tulchinsky H (2014) Is there a role for adjuvant chemotherapy in pathological complete response rectal cancer tumors following neoadjuvant chemoradiotherapy? J Cancer Res Clin Oncol [Epub ahead of print]

  • Hsia TC, Tu CY, Chen HJ, Chien CR (2013) Effectiveness of intensity-modulated radiotherapy for lung cancer. Clin Oncol (R Coll Radiol) 25:447–448

    Article  CAS  Google Scholar 

  • Ke TW, Liao YM, Chiang HC, Chang SC, Wang PH, Chen YY, Chen WT, Chien CR (2014) Effectiveness of neoadjuvant concurrent chemoradiotherapy versus up-front proctectomy in clinical stage II–III rectal cancer: a population-based study. Asia Pac J Clin Oncol. doi:10.1111/ajco.12172

    PubMed  Google Scholar 

  • Lin CC, Hsia TC, Chien CR (2012) 3rd line Erlotinib for lung cancer in Asia may be as cost-effective as in the Western world. Lung Cancer 76:499–500

    Article  PubMed  Google Scholar 

  • Nelson VM, Benson AB 3rd (2013) Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy. Curr Oncol Rep 15:152–161

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The data analyzed in this study were provided by the Collaboration Centre for Health Information Application (CCHIA), Department of Health, Executive Yuan, Taiwan. We thanked the Health and welfare surcharge of tobacco products, China Medical University Hospital Cancer Research Center of Excellence (MOHW103-TD-B-111-03, Taiwan), for their financial support. The authors—not the CCHIA or the funding body—had full control of the design of the study, methods used, outcome parameters and results, analysis of data and production of the written report.

Conflict of interest

The authors declared no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chun-Ru Chien.

Additional information

William Tzu-Liang Chen, Tao-Wei Ke and Chia-Chin Li have equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, W.TL., Ke, TW., Li, CC. et al. Questionable role of adjuvant chemotherapy in rectal cancer patients who had reached pathological complete response after neoadjuvant concurrent chemoradiotherapy: no matter in the East or in the West. J Cancer Res Clin Oncol 140, 1495–1496 (2014). https://doi.org/10.1007/s00432-014-1749-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-014-1749-5

Keywords

Navigation